Comparative Effectiveness of Buprenorphine Adherence with Telemedicine Versus In-Person for Rural and Urban Patients
Link
Description
Compares adherence to buprenorphine for opioid use disorder
in telemedicine versus in-person healthcare in rural and
urban populations. Utilizes 2017–2022 data from 511 adults
and compares 3,302 in-person and 519 telemedicine visits,
with breakdowns according to patient characteristics,
adherence, gaps in treatment, and rural versus urban
location. Discusses changing legislative requirements
related to buprenorphine treatment and the potential impact
on rural populations.
Author(s)
Thomas J. Reese, Nana Addo Padi-Adjirackor, Kevin N. Griffith, et al.
Citation
Journal of the American Pharmacists Association, 65(2), 102318
Date
03/2025
Tagged as
Access
· Illicit drug use
· Legislation and regulations
· Prescription drug misuse
· Rural-urban differences
· Specialty care
· Statistics and data
· Telehealth